127 related articles for article (PubMed ID: 11579815)
21. [Cisplatin, 5-fluorouracil and leucovorin combination chemotherapy-added radiation therapy for advanced esophageal cancer--a case report].
Hokita S; Fukura K; Imamura H; Kimura S; Toyoyama H; Hamahata H; Nakai H; Imakiire K; Okubo K; Miyaji K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):399-402. PubMed ID: 7880112
[TBL] [Abstract][Full Text] [Related]
22. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
23. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
24. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
Ajani JA; Walsh G; Komaki R; Morris J; Swisher SG; Putnam JB; Lynch PM; Wu TT; Smythe R; Vaporciyan A; Faust J; Cohen DS; Nivers R; Roth JA
Cancer; 2004 Jun; 100(11):2347-54. PubMed ID: 15160337
[TBL] [Abstract][Full Text] [Related]
25. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
26. [Radio- and chemotherapy of cancer of the esophagus].
Tiret E
Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
[TBL] [Abstract][Full Text] [Related]
27. [Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy].
Ando N; Ozawa S; Kitagawa Y; Takeuchi H; Kitajima M
Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):767-72. PubMed ID: 9370137
[TBL] [Abstract][Full Text] [Related]
28. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
Ruhstaller T; Pless M; Dietrich D; Kranzbuehler H; von Moos R; Moosmann P; Montemurro M; Schneider PM; Rauch D; Gautschi O; Mingrone W; Widmer L; Inauen R; Brauchli P; Hess V
J Clin Oncol; 2011 Feb; 29(6):626-31. PubMed ID: 21205757
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
30. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
[TBL] [Abstract][Full Text] [Related]
31. Irinotecan in esophageal cancer.
Enzinger PC; Ilson DH
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):26-30. PubMed ID: 11200145
[TBL] [Abstract][Full Text] [Related]
32. [Neoadjuvant chemotherapy and concurrent radiochemotherapy for advanced esophageal carcinoma potentially invading adjacent structures].
Aoyama N; Koizumi H
Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):761-6. PubMed ID: 9370136
[TBL] [Abstract][Full Text] [Related]
33. The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Malthaner RA; Yu E; Sanatani M; Lewis D; Warner A; Dar AR; Yaremko BP; Bierer J; Palma DA; Fortin D; Inculet RI; Fréchette E; Raphael J; Gaede S; Kuruvilla S; Younus J; Vincent MD; Rodrigues GB
Thorac Cancer; 2022 Jul; 13(13):1898-1915. PubMed ID: 35611396
[TBL] [Abstract][Full Text] [Related]
34. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
35. [A curative resected case of pathological complete response of esophageal carcinoma treated with 5-FU/CDDP as neoadjuvant chemotherapy].
Kusano T; Noguchi T; Ogawa T; Inomata M; Shiraishi N; Kitano S
Gan To Kagaku Ryoho; 2011 Jan; 38(1):97-100. PubMed ID: 21368466
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel in the treatment of esophageal cancer.
Weiner LM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
Yokota T; Hatooka S; Ura T; Abe T; Takahari D; Shitara K; Nomura M; Kondo C; Mizota A; Yatabe Y; Shinoda M; Muro K
Anticancer Res; 2011 Oct; 31(10):3535-41. PubMed ID: 21965775
[TBL] [Abstract][Full Text] [Related]
39. [Neoadjuvant chemoradiotherapy in esophageal cancer].
Cordiano C; Laterza E; Urso SU; Castaldini G
Chir Ital; 1994; 46(3):11-5. PubMed ID: 8001187
[TBL] [Abstract][Full Text] [Related]
40. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
